Moderna, Inc
Head Quarters
200 Technology Square USWebsite
http://www.modernatx.comIndustry
BiotechnologyEmployees
830Exchange
NASDAQGSModerna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Key statistics
Margins | Stock |
---|---|
Revenue per Employee | $0.00 |
Current Ratio | |
Gross Margin (%) | 0.00% |
Net Margin (%) | 0.00% |
Returns | Stock |
Sales | $0.00 |
Sales Growth (% qtr vs. yr ago) | 0.00% |
Net Income | $0.00 |
NI Growth (% qtr vs. yr ago) | 0.00% |
Price/Sales | 0.00 |
EPS | $0.00 |